Skip to main content
Clinical Trials/JPRN-UMIN000035081
JPRN-UMIN000035081
Recruiting
未知

Quantitative blood-brain barrier permeability and susceptibility mapping for patients with CADASIL and suspected to have CADASIL - BBB permeability and QSM for CADASI

agoya City University0 sites40 target enrollmentDecember 1, 2018
ConditionsCADASI

Overview

Phase
未知
Intervention
Not specified
Conditions
CADASI
Sponsor
agoya City University
Enrollment
40
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2018
End Date
October 31, 2021
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
agoya City University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who are prohibited to take MRI

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Blood-Brain Barrier permeability quantification in cerebral small vessel disease -- reproducibility of dynamic contrast-enhanced MRICerebral small vessel diseasedisease of the small brain arteries10007963
NL-OMON38519Medisch Universitair Ziekenhuis Maastricht20
Active, not recruiting
Not Applicable
Studies on Permeability of the Blood-Brain-Barrier for Escitaloprame related to various Genotypes of the ABCB1-Gene: Effects on Sleep and Motoric Learning - Escitaloprame, sleep, blood-brain-barrierEffects on sleep electroencephalogram and motoric learning in healthy volunteers related to the permeability of the blood-brain-barrier related to genotypes of the ABCB 1 gene
EUCTR2006-001491-21-DEMax Planck Institute of Psychiatry58
Recruiting
Not Applicable
Blood-brain barrier permeability and cerebral perfusion in Alzheimer*s diseaseneurodegeneratieve aandoeningenAlzheimer's diseasedementia
NL-OMON38302niversiteit Maastricht60
Active, not recruiting
Not Applicable
Permeability of the blood-brain barrier in Alzheimer’s disease
ISRCTN17419165niversity of Southampton70
Recruiting
Not Applicable
Blood brain barrier permeability and inflammatory biomarkers in patients with depressioF32.2F32.3F33.2F33.3Severe depressive episode without psychotic symptomsSevere depressive episode with psychotic symptomsRecurrent depressive disorder, current episode severe without psychotic symptomsRecurrent depressive disorder, current episode severe with psychotic symptoms
DRKS00022091Klinik für Psychiatrie, Psychosomatik und PsychotherapieUniversitätsklinikum Frankfurt100